Found 22 matching trials
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Show More Status
Active Not Recruiting
Location
Childrens National Medical Center
Learn More & Join Trial
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation PHASE2 High risk MDS (Myelodysplastic Syndrome) patients will be treated with SGI-...
Show More Learn More & Join Trial
Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy PHASE1 Allo-hsct is potentially curative method of treatment for children and adol...
Show More Location
RM Gorbacheva Research Institute
Learn More & Join Trial
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies PHASE2 Unmanipulated allogenic peripheral blood stem cell transplantation (allo-PB...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation N/A The purpose of this study is to evaluate the feasibility and efficacy of re...
Show More Location
Asan Medical Center
Learn More & Join Trial
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation PHASE1 This is a new platform in non-myeloablative allogeneic stem cell transplant...
Show More Location
Abramson Cancer Center at University of Pennsylvania
Learn More & Join Trial
Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation PHASE1 Pilot, multicentric, open-label, single-arm, phase I-II clinical trial to e...
Show More Location
Hospital Universitari Germans Trias i Pujol
Learn More & Join Trial
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies NA This study is being done to assess the safety and determine the maximum tol...
Show More Location
UW Carbone Cancer Center
Learn More & Join Trial
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia NA CAR-T therapy has evolved as a pivotal treatment for relapsed/refractory (R...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT PHASE1 The primary objective of this proposal is to conduct the first-in-human ran...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial